NYSE: MMA Highlights 41-Pound Health Transformation at UFC GYM Through TrainAlta
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting
BlockchAIn to Host Virtual Investor Webinar on Tuesday, April 28, 2026 at 12:00 p.m. Eastern Time
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
